14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ATOS stock ended at $1.70. This is 1.16% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 6.59% from a day low at $1.67 to a day high of $1.78.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Oct 18, 2016 $21.12 $21.72 $21.00 $21.60 1 850
Oct 17, 2016 $21.72 $21.72 $20.40 $20.76 1 267
Oct 14, 2016 $21.84 $22.44 $21.60 $22.08 792
Oct 13, 2016 $22.68 $22.68 $21.48 $21.84 4 975
Oct 12, 2016 $23.64 $23.64 $22.80 $22.92 925
Oct 11, 2016 $23.40 $23.40 $21.96 $23.40 2 067
Oct 10, 2016 $23.76 $24.00 $23.52 $23.88 233
Oct 07, 2016 $24.12 $24.60 $23.88 $24.00 2 033
Oct 06, 2016 $24.84 $25.32 $23.28 $24.36 775
Oct 05, 2016 $23.88 $25.20 $23.88 $24.72 433
Oct 04, 2016 $24.72 $25.44 $21.36 $24.00 7 692
Oct 03, 2016 $24.96 $25.56 $24.12 $24.96 1 225
Sep 30, 2016 $24.48 $25.68 $24.48 $25.20 758
Sep 29, 2016 $25.20 $26.04 $24.48 $24.84 1 733
Sep 28, 2016 $24.84 $26.16 $24.84 $25.80 900
Sep 27, 2016 $24.48 $24.84 $24.00 $24.36 2 608
Sep 26, 2016 $26.28 $26.28 $24.60 $24.84 1 725
Sep 23, 2016 $25.92 $26.28 $25.32 $26.16 1 075
Sep 22, 2016 $26.40 $27.48 $25.80 $25.92 3 525
Sep 21, 2016 $26.04 $26.52 $25.20 $26.28 3 683
Sep 20, 2016 $24.60 $26.16 $24.00 $26.04 3 983
Sep 19, 2016 $24.60 $25.68 $24.24 $24.24 1 917
Sep 16, 2016 $26.28 $26.64 $24.60 $24.72 3 217
Sep 15, 2016 $27.00 $27.96 $25.80 $26.04 3 208
Sep 14, 2016 $25.80 $28.56 $25.68 $27.24 6 642
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT